CS Lyases: Structure, Activity, and Applications in Analysis and the Treatment of Diseases

Advances in Pharmacology

Volumn 53, Issue , 2006, Pages 187-215

  Linhardt, Robert J ^a   Avci, Fikri Y ^a   Toida, Toshihiko ^b   Kim, Yeong Shik ^c   Cygler, Miroslaw ^d  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c Seoul National University   (South Korea)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN;

CHEMISTRY; METABOLISM; REVIEW;

CHONDROITIN LYASES; CHONDROITIN SULFATES; DERMATAN SULFATE; GLYCOSAMINOGLYCANS;

EID: 33846172034     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)53009-6     Document Type: Review

References (111)

1. Ahn M., Shin K., Kim D.-H., Jang E.-A., Toida T., Linhardt R., and Kim Y. Characterization of a bacteroides species from human intestine that degrades glycosaminoglycans. Can. J. Microbiol. 44 (1998) 423-429
2. Al-Hakim A., and Linhardt R.J. Capilary electrophoresis for the analysis of chondroitin sulfate and dermatan sufate derived disaccharides. Anal. Biochem. 195 (1991) 68-73
3. Avci F.Y., Toida T., and Linhardt R.J. Chondroitin O-methyl ester: An unusual substrate for chondroitin AC lyase. Carbohydr. Res. 338 (2003) 2101-2104
4. Avci F.Y., Karst N., Islam T., and Linhardt R.J. Trifluoroethylsulfonate protected monosaccharides in glycosylation reactions. 228th ACS National Meeting, Philadelphia (2004)
5. Blain F., Tkalec A.L., Shao Z., Poulin C., Pedneault M., Gu K., Eggimann B., Zimmermann J., and Su H. Expression system for high levels of GAG lyase gene expression and study of the hepA upstream region in Flavobacterium heparinum. J. Bacteriol. 184 (2002) 3242-3252
6. Boneu B. Glycosaminoglycans: Clinical use. Sem. Thromb. Hemost. 22 (1996) 209-212
7. Bourne Y., and Henrissat B. Glycoside hydrolases and glycosyltransferases: Families and functional modules. Curr. Opin. Struct. Biol. 11 (2001) 593-600
8. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennet G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
9. Capila I., and Linhardt R.J. Heparin protein interactions. Angew. Chemie Int. Ed. 41 (2002) 390-412
10. Csóka A.B., Scherer S.W., and Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 60 (1999) 356-361
11. Davies G.J., Wilson K.S., and Henrissat B. Nomenclature for sugar-binding subsites in glycosyl hydrolases. Biochem. J. 321 (1997) 557-559
12. Davies S.J., Gaucher D.R., Doller C., and Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosis. 19 (1999) 5810-5822
13. DeAngelis P.L. Hyaluronan synthases: Fascinating glycosyltransferases from vertabrates, bactrerial pathogens and algal viruses. Cell Mol. Life Sci. 56 (1999) 670-682
14. Denholm E.M., Lin Y.Q., and Silver P.J. Anti-tumor activities of chondroitinase AC and chondroitinase B: Inhibition of angiogenesis, proliferation and invasion. Eur. J. Pharmacol. 416 (2001) 213-221
15. Ernst S., Langer R., Cooney C.L., and Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 44-45
16. Esko J.D., and Selleck S.B. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71 (2002) 435-471
17. Fawcett J.W., and Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49 (1999) 377-391
18. Féthière J., Eggimann B., and Cygler M. Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J. Mol. Biol. 288 (1999) 635-647
19. Fidler P.S., Schuette K., Asher R.A., Dobbertin A., Thornton S.R., Calle-Patino Y., Muir E., Levin J.M., Geller H.M., Rogers J., Faissner A., and Fawcett J.W. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: The major axon-inhibitory proteoglycans is NG2. J. Neurosis. 19 (1999) 8778-8788
20. Fitch M.T., and Silver J. CNS regeneration. In: Tusynski M.H., and Kordower J.H. (Eds). "Basic Science and Clinical Advances" (1999), Academic Press, San Diego 55-58
21. Frost G.I., Csoka T., and Stern R. The hyaluronidases: A chemical, biological and clinical overview. Trends Glycosci. Glycotechnol. 44 (1996) 419-434
22. Godavarti R., and Sasisekharan R. Heparinase I from Flavobacterium heparinum: Role of positive charge in enzymatic activity. J. Biol. Chem. 273 (1998) 248-255
23. Gu K., Liu J., Pervin A., and Linhardt R.J. Comparison of the activity of two chondroitin AC lyases on dermatan sulfate. Carbohydr. Res. 244 (1993) 369-377
24. Gu K., Linhardt R.J., Laliberte M., Gu K., and Zimmermann J. Purification, characterization and specificity of chondroitin lyases and glycuronidase from Flavobacterium heparinum. Biochem. J. 312 (1995) 569-577
25. Guthrie J.P., and Kluger R. Electrostatic stabilization can explain the unexpected acidity of carbon acids in enzyme-catalyzed reactions. J. Am. Chem. Soc. 115 (1993) 11569-11572
26. Hamai A., Hashimoto N., Mochizuki H., Kato F., Makiguchi Y., Horie K., and Suzuki S. Two distinct chondroitin sulfate ABC lyases: An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides. J. Biol. Chem. 272 (1997) 9123-9130
27. Hannesson H.H., Hagner-McWhirter A., Tiedemann K., Lindahl U., and Malmstrom A. Biosynthesis of dermatan sulfate: Defructosylated Escherichia coli K4 capsular polysaccharide as a substrate for the D-glucuronyl C-5 epimerase, and an indication of a two-base reaction mechanism. Biochem. J. 313 (1996) 589-596
28. Hernáiz M.J., and Linhardt R.J. Degradation of chondroitin and dermatan sulfate with chondroitin lyases. In: Iozzo R.V. (Ed). "Methods in Molecular Biology" (2001), Humane Press, New York
29. Hirano K., Sakai S., Ishikawa T., Avci F.Y., Linhardt R.J., and Toida T. Preparation of hyaluronan Omethylester and its enzymatic degradation. Carbohydr. Res. 338 (2005) 2101-2104
30. Hong S.-W., Kim B.-T., Shin H.-Y., Kim W.-S., Lee K.-S., Kim Y.-S., and Kim D.-H. Purification and characterization of novel chondroitin ABC and AC lyases from Bacteroides stercoris HJ-15, a human intestinal anaerobic bacterium. Eur. J. Biochem. 269 (2002) 2934-2940
31. Hoshi H., Nakagawa H., Nishiguchi S., Iwata K., Niikura K., Monde K., and Nishimura S. An engineered hyaluronan synthase 2 expressed in Escherichia coli. J. Biol. Chem. 279 (2004) 2341-2349
32. Huang W., Matte A., Li Y., Kim Y.S., Linhardt R.J., Su H., and Cygler M. Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 Å resolution. J. Mol. Biol. 294 (1999) 1257-1269
33. Huang W., Matte A., Suzuki S., Sugiura N., Miyazono H., and Cygler M. Crystallization and preliminary x-ray analysis of chondroitin sulfate ABC lyases I and II from Proteus vulgaris. Acta Crystallogr. D56 (2000) 904-906
34. Huang W., Boju L., Tkalec L., Su H., Yang H.O., Gunay N.S., Linhardt R.J., Kim Y.S., Matte A., and Cygler M. Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry 40 (2001) 2359-2372
35. Huang W., Lunin V.V., Li Y., Suzuki S., Sugiura N., Miyazono H., and Cygler M. Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at 1.9 Å resolution. J. Mol. Biol. 328 (2003) 623-634
36. Hynes W.L., and Walton S.L. Hyaluronidases of Gram-positive bacteria. FEMS Microbial. Lett. 183 (2000) 201-207
37. Ingham E., Holland K.T., Gowland G., and Cunliffe W.J. Purification and partial characterization of hyaluronate lyase (EC 4.2.2.1) from Propionibacterium acnes. J. Gen. Microbiol. 115 (1979) 411-418
38. Iozzo R.V. Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem. 67 (1998) 609-652
39. Islam T., Avci F.Y., Karst N., Zhang J., and Linhardt R.J. Disaccharide approach for the synthesis of glycosaminoglycan oligosaccharides. 226th ACS National Meeting, New York (2003)
40. Itano N., and Kimata K. Mammalian hyaluronan synthases. IUMB Life 54 (2002) 195-199
41. Jackson R.L., Busch S.J., and Cardin A.D. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71 (1991) 481-539
42. Jandik K.A., Gu K., and Linhardt R.J. Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology 4 (1994) 289-296
43. Karst N.A., Islam T.F., and Linhardt R.J. Sulfo-protected hexosamine monosaccharides: Potentially versatile building blocks for glycosaminoglycan synthesis. Org. Lett. 5 (2003) 4839-4842
44. Karst N.A., Islam T.F., Avci F.Y., and Linhardt R.J. Trifluoroethylsulfonate protected monosaccharides in glycosylation reactions. Tetrahedron Lett. 45 (2004) 6433-6437
45. Kato F., Iwata H., Hiatus K., and Miura T. Experimental chemonucleolysis with chondroitinase ABC. Clin. Ortho. 253 (1990) 301-308
46. Kempson G.E. The mechanical properties of articular cartilage. In: Sokoloff L. (Ed). "The Joints and Synovial Fluid" Vol. 2 (1980), Academic Press, New York 177-238
47. Kim B.-T., Kim W.-S., Kim Y.S., Linhardt R.J., and Kim D.-H. Purification and characterization of a novel heparinase from Bacteroides stercoris HJ-15. J. Biochem. Tokyo 128 (2000) 323-328
48. Kim Y.S., Jo Y.T., Chang I.M., Toida T., Park Y., and Linhardt R.J. A new glycosaminoglycan from the giant african snail, Achatina fulica. J. Biol. Chem. 271 (1996) 11750-11755
49. Kitagawa H., Tanaka Y., Yamada S., Seno N., Haslam S.M., Morris H.R., Dell A., and Sugahara K. A novel pentasaccharide sequence GlcA(3-sulfate)(beta1-3)GalNAc(4-sulfate)(beta1-4)(Fuc alpha1-3)GlcA(beta1-3)GalNAc(4-sulfate) in the oligosaccharides isolated from king crab cartilage chondroitin sulfate K and its differential susceptibility to chondroitinases and hyaluronidase. Biochemistry 36 (1997) 3998-4008
50. Kitagawa H., Uyama T., and Sugahara K. Molecular cloning and expression of a human chondroitin synthase. J. Biol. Chem. 276 (2001) 38721-38726
51. Kitagawa H., Izumikawa T., Uyama T., and Sugahara K. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J. Biol. Chem. 278 (2003) 23666-23671
52. Kreil G. Hyaluronidases: A group of neglected enzymes. Protein Sci. 4 (1995) 1666-1669
53. Kresse H., and Schonherr E. Proteoglycans of the extracellular matrix and growth control. J. Cell Physiol. 189 (2001) 266-274
54. Lamb D.J., Wang H.M., Mallis L.M., and Linhardt R.J. Negative-ion fast atom bombardment tandem mass spectrometry to determine sulfate and linkage position in glycosaminoglycan-derived disaccharides. J. Am. Soc. Mass Spectrom 3 (1992) 797-803
55. Langer R., Linhardt R.J., Hoffberg S., Larsen A.K., Cooney C.L., Topper D., and Klein M. An enzymatic system for removing heparin in extracorporeal therapy. Science 217 (1982) 261-263
56. Leroy J.G., and Wiesmann U. Disorders of lysosomal enzymes. In: Royce P., and Steinmann B. (Eds). "Connective Tissue and its Heritable Disorders: Molecular, Genetic, and Medical Aspects" (1993), Wiley, New York 613-639
57. Li J.P., Hagner-McWhirter A., Kjellen L., Palgi J., Jalkanen M., and Lindahl U. Biosynthesis of heparin/heparan sulfate: cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J. Biol. Chem. 272 (1997) 28158-28163
58. Li S., Kelly S.J., Lamani E., Ferraroni M., and Jedrzejas M.J. Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J. 19 (2000) 1228-1240
59. Linhardt R.J., Galliher P., and Cooney C. Plysaccharide lyases. Appl. Biochem. Biotechnol. 12 (1986) 135-176
60. Linhardt R.J., Rice K.G., Kim Y.S., Lohse D.L., Wang H.M., and Loganathan D. Mapping and quantification of the major oligosaccharide components of heparin. Biochem. J. 254 (1988) 781-787
61. Linhardt R.J., Al-Hakim A., Liu J., Hoppensteadt D., Mascelanni P., and Fareed J. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem. Pharm. 42 (1991) 1609-1619
62. Linhardt R.J., and Al-Hakim A. Biocatalysis for the synthesis and modification of biopolymers. In: Dordick J.S. (Ed). "Biocatalysis for Industry: Topics in Applied Chemistry" Vol. 5 (1991), Plenum Publishing Company, New York 83-112
63. Linhardt R.J., Ampofo S., Fareed J., Hoppensteadt D., Mulliken J., and Folkman J. Isolation and characterization of a human heparin. Biochemistry 31 (1992) 12441-12445
64. Linhardt R.J. Analysis of glycosaminoglycans with polysaccharide lyases. In: Varki A. (Ed). "Current Protocols in Molecular Biology, Analysis of Glycoconjugates" Vol. 2 (1994), Wiley Interscience, Boston 17.13.17-17.13.32
65. Linhardt R.J., Desai U., Liu J., Pervin A., Hoppensteadt D., and Fareed J. Low molecular weight dermatan sulfate as an antithrombotic agent. Biochem. Pharmacol. 47 (1994) 1241-1252
66. Linhardt R.J., and Toida T. Role of glycosaminoglycans in cellular communication. Acc. Chem. Res. 37 (2004) 431-438
67. Loganathan D., Wang H.M., Mallis L.M., and Linhardt R.J. Structural variation of the antithrombin III binding site and its occurrence in heparin from different sources. Biochemistry 29 (1990) 4362-4368
68. Lunin V.V., Li Y., Linhardt R.J., Miyazano H., Kyogashima M., Kaneko T., Bell A.W., and Cygler M. High-resolution crystal structure of Arthrobacter aurescens chondroitin AC lyase: An enzyme-substrate complex defines the catalytic mechanism. J. Mol. Biol. 337 (2004) 367-386
69. Madan A.K., Yu K., Dhurandhar N., Cullinane C., Pang Y., and Beech D.J. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol. Rep. 6 (1999) 607-609
70. Madan A.K., Pang Y., Wilkiemeyer M.B., Yu D., and Beech D.J. Increased hyaluronidase expression in more aggressive prostate adenocarcinoma. Oncol. Rep. 6 (1999) 1431-1433
71. McCourt P.A.G. How does the hyaluronan scrap-yard operate. Matrix Biol. 18 (1999) 427-432
72. McKeon R.J., Schreiber R.C., Rudge J.S., and Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosis. 11 (1991) 3398-3411
73. McKeon R.J., Hoke A., and Silver J. Injury-induced proteoglycans inhibit the potential for laminmediated axon growth on astrocytin scars. Exp. Neural. 136 (1995) 32-43
74. Michaud P., Da Costa A., Courtois B., and Courtois J. Polysaccharide lyases: Recent developments as biotechnological tools. Crit. Rev. Biotechnol. 23 (2003) 233-266
75. Michel G., Pojasek K., Li Y., Sulfa T., Linhardt R.J., Raman R., Probhakar V., Sasisekharan R., and Cygler M. The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J. Biol. Chem. 279 (2004) 32882-32896
76. Miller A.D. Identification of Hyal2 as the cell-surface receptor for jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus. Curr. Top Microbiol. Immunol. 275 (2003) 179-199
77. Monslow J., Williams J.D., Nurton N., Guy C.A., Price I.K., Coleman S.L., Williams N.M., Buckland P.R., Spicer A.P., and Topley N. The human hyaluronan synthase genes: Genomic structures, proximal promoters and polymorphic microsatellite markers. Int. J. Biochem. Cell Biol. 35 (2003) 1272-1283
78. Moon A.F., Edavettal S.C., Krahn J.M., Munoz E.M., Negishi M., Linhardt R.J., Liu J., and Pedersen L.C. Structural analysis of the sulfotransferase (3-OST-3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J. Biol. Chem. 279 (2004) 45185-45193
79. Moon L.D., Asher R.A., Rhodes K.E., and Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinases ABC. Nat. Neurosci. 4 (2001) 465-466
80. Negishi M., Dong J., Darden T.A., Pedersen L.G., and Pedersen L.C. Glycosaminoglycan biosynthesis: What we can learn from the X-ray crystal structures of glycosyl transferases GlcAT1 and EXTL2. Biochem. Biohys. Res. Commun. 303 (2003) 393-398
81. Niederost B.P., Zimmermann D.R., Schwab M.E., and Bandtlow C.E. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J. Neurosis. 19 (1999) 8979-8989
82. Ninomiya T., Sugiura N., Tawada A., Sugimoto K., Watanabe H., and Kimata K. Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4. J. Biol. Chem. 277 (2002) 21567-21575
83. Novak U., Stylli S.S., Kaye A.H., and Lepperdinger G. Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res. 59 (1999) 6246-6250
84. Pervin A., Gu K., and Linhardt R.J. Capilary electrophoresis to measure sulfoesterase activity on chondroitin sulfate and heparin derived disaccharides. Appl. Theor. Electroph. 3 (1993) 297-303
85. Pervin A., Al-Hakim A., and Linhardt R.J. Separation of glycosamionoglycan derived oligosaccharides by capilary electrophoresis using reverse polarity. Anal. Biochem. 221 (1994) 182-188
86. Pervin A., Gallo C., Jandik K.A., Han X.J., and Linhardt R.J. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology 5 (1995) 83-95
87. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., and Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298 (2002) 1248-1251
88. Pojasek K., Shriver Z., Kiley P., Venkataraman G., and Sasisekharan R. Recombinant expression, purification, and kinetic characterization of chondroitinase AC and chondroitinase B from Flavobacterium heparinum. Biochem. Biophys. Res. Commun. 286 (2001) 343-351
89. Prabhakar V., Capila I., Bosques C.J., Pojasek K., and Sasisekharan R. Chondroitinase ABC I from Proteus vulgaris: Cloning, recombinant expression and active site identification. Biochem. J. 386 (2005) 103-112
90. Proud A.D., Prodger J.C., and Flitsch S.L. Development of a protecting group for sulfate esters. Tetrahedron Lett. 38 (1997) 7243-7246
91. Razi N., Feyzi E., Bjork I., Naggi A., Casu B., and Lindahl U. Structural and functional properties of heparin analogs obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide. Biochem. J. 309 (1995) 465-472
92. Rigden D.J., and Jedrzejas M.J. Structures of Streptococcus pnemoniae hyaluronate lyase in complex with chondroitin and chondroitin sulfate disaccharides. J. Biol. Chem. 278 (2003) 50596-50606
93. Rosenberg R.D., Shworak N.W., Liu J., Schwartz J.J., and Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?. J. Clin. Invest. 99 (1997) 2062-2070
94. Seidler D.G., Breuer E., Grande-Allen K.J., Hascall V.C., and Kresse H. Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J. Biol. Chem. 279 (2002) 25789-25797
95. Silbert J.E., and Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUMB Life 54 (2002) 177-186
96. Sim J.S., Jun G., Toida T., Cho S.Y., Choi D.W., Chang S.Y., Linhardt R.J., and Kim Y.S. Quantitative analysis of chondroitin sulfate in raw materials, ophthalmic solutions, soft capsules and liquid preparations. J. Chromatogr. B 818 (2005) 133-139
97. Smith-Thomas L.C., Fok-seang J., Stevene J., Du J., Muir E., Faissner A., Geller H.M., Rogers J.H., and Fawcett J.W. An inhibitor of neurite outgrowth produced by astrocytes. J. Cell Sci. 107 (1994) 1687-1695
98. Spicer A.P., and McDonald J.A. Characterization and molecular evolution of a vertabrate hyaluronan synthase gene family. J. Biol. Chem. 273 (1998) 1923-1932
99. Stringer S.E., and Callagher J.T. Heparan sulphate. Int. J. Biochem. Cell Biol. 29 (1997) 709-714
100. Sugahara K., and Kitagawa H. Heparin and heparan sulfate biosynthesis. IUMB Life 54 (2002) 163-175
101. Sztrolovics R., Recklies A.D., Roughley P.J., and Mort J. Hyaluronate degradation as an alternate mechanism for proteoglycan release from cartilage during interleukin-1ß-stimulated catabolism. Biochem. J. 362 (2002) 473-479
102. Thorp S., Lee K.A., Negishi M., Linhardt R.J., Liu J., and Pedersen L.C. Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J. Biol. Chem. 279 (2004) 25789-25797
103. Uyama T., Kitagawa H., Tanaka J., Tamura J., Ogawa T., and Sugahara K. Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate. J. Biol. Chem. 278 (2003) 3072-3078
104. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., Bitan M., Pappo O., Peretz T., Michal I., Spector L., and Pecker I. Mammalian heparanse: Gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 5 (1999) 793-802
105. Weiler J.M., Edens R.E., Linhardt R.J., and Kapelanski D.P. Heparin and modified heparin inhibit complement activation in vivo. J. Immunol. 148 (1992) 3210-3215
106. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., Hooper L.V., and Gordon J.I. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299 (2003) 2074-2076
107. Yada T., Sato T., Kaseyama H., Gotoh M., Iwasaki H., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Watanabe H., Narimatsu H., and Kimata K. Chondroitin sulfate synthase-3: Molecular cloning and characterization. J. Biol. Chem. 278 (2003) 39711-39725
108. Yang H.O., Gunay N.S., Toida T., Kuberan B., Yu G., Kim Y.S., and Linhardt R.J. Preparation and structural determination of dermatan sulfate-derived oligosaccharides. Glycobiology 10 (2000) 1033-1040
109. Yao X.Y., Hageman G.S., and Marmor M.F. Recovery of retinal adhesion after enzymatic perturbation of the interphotoreceptor matrix. Invest. Ophthalmol. Vis. Sci. 33 (1992) 498-503
110. Zechel D.L., and Withers S.G. Glycosidase mechanism: Anatomy of a finely tuned catalyst. Acc. Chem. Res. 33 (2000) 11-18
111. Zuo J., Neubauer D., Dyes K., Ferguson T.A., and Muir D. Degradation of chondroitin sulfate proteoglycans enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 154 (1998) 654-662